Finerenone Production Cost Reports

The report provides a detailed analysis essential for establishing a Finerenone production plant. It encompasses all critical aspects necessary for Finerenone production, including the cost of Finerenone production, Finerenone plant cost, Finerenone production costs, and the overall Finerenone production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Finerenone production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Finerenone is a prescription medicine used mainly for people with chronic kidney disease linked to type 2 diabetes. It works by blocking mineralocorticoid receptors, which helps reduce inflammation and fibrosis in the kidneys and heart. It finds its major application in slowing the progression of kidney damage and lowering the risk of cardiovascular complications in affected patients. It is often prescribed as part of long-term treatment plans to delay the need for dialysis or kidney transplantation. It is also useful in reducing hospitalisations caused by heart failure in people with diabetes-related kidney issues. It is also used in research studies to explore better ways of managing diabetic kidney issues and improving outcomes for patients who require ongoing support.

The market for Finerenone is predominantly led by its use as a medication for managing chronic kidney disease (CKD) associated with type 2 diabetes, which drives its demand in the pharmaceutical industry. Its application as an oral drug in long-term care programs for the treatment of chronic kidney disease (CKD) and reduce kidney-related complications also promotes its demand in the medical sector. Its involvement as a drug in treatment plans to slow kidney function decline and lower the chance of complications like swelling or fluid buildup further boosts its demand in the healthcare sector.

Its demand as an important therapeutic option in modern nephrology and cardiology also contributes to its market expansion. Furthermore, several key factors, including the availability and cost of starting materials, regulatory approvals, patent protections, and adherence to environmental and production guidelines, impact industrial Finerenone procurement. Technological improvements in synthesis routes, consistent quality control, reliable supply chains, and sustainability initiatives also play a major role in shaping its procurement processes.

Raw Material for Finerenone Production

According to the Finerenone production plant project report, the major raw materials for Finerenone production include Benzaldehyde and Pyridyl Chloride.

Production Process of Finerenone

The extensive Finerenone production cost report consists of the following industrial production process:

1. Production via Chemical Synthesis: The production process of Finerenone begins with the condensation of benzaldehyde and acetoacetamide under Knoevenagel conditions to form an enone intermediate. In parallel, pyridyl chloride is treated under strong basic conditions at high temperature, followed by an acid bath to produce a pyridone compound. Then, these two intermediates are reacted together in heated isobutanol, which leads to a condensation and cyclisation that forms an azacycle core structure. The pyridone group in this intermediate is then converted to an ethyl ether using 1,1,1-triethoxyethane under acidic conditions. The resulting racemic mixture is resolved using tartaric acid-derived salts, and the desired enantiomer is isolated and further purified through reslurrying. Finally, pH adjustment with sodium carbonate in a water-ethanol mixture leads to the formation of Finerenone with high enantiomeric purity as the final product.

Finerenone is a non-steroidal, selective mineralocorticoid receptor antagonist used as an oral medication to reduce the risk of kidney function decline, kidney failure, and cardiovascular death. It is prescribed for adults with chronic kidney disease associated with type 2 diabetes to lower the risk of hospitalisation for heart failure. The molecular formula of Finerenone is C21H22N4O3, and its molar mass is 378.43 g/mol. It exists as a white to off-white solid crystalline substance and does not have a defined odour. It has a high boiling point of 555 degree Celsius. The density of the pure compound is around 1.29 g/cm3. It is generally insoluble in water but soluble in organic solvents, such as dimethyl sulfoxide and dimethylformamide. It is a biologically active pharmaceutical ingredient, so its handling should be closely monitored in production and clinical settings, as unintended exposure can pose health risks. It must be used only under prescribed medical supervision due to potential side effects, including electrolyte imbalances and hypotension.